Abstracts
Showing 800 abstracts.
Immunogenicity of ALVAC-HIV vCP1521 in Infants Born to HIV-1 Infected Women in Uganda (HPTN 027)
Conference
AIDS
Tenofovir population pharmacokinetics in HIV-infected children and adolescents
Tenofovir Disoproxil Fumarate (TDF) Pharmacokinetics (PK) with Increased Doses in HIV-1 Infected Pregnant Women and their Newborns (HPTN 057)
Prevalence and characterization of HIV-associated nephropathy and other renal disorders in a cohort of perinatally HIV-1 infected children
Challenges to participant recruitment into a phase 111 safety and efficacy trial of extended nevirapine dosing in breastfeeding infants born to HIV-infected Ugandan women
Vitamin D Levels and TMEM16J Host Variants are Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants
Study
P1041
Equipoise is in the eye of the beholder: Issues in clinical trial design and implementation when there are regional differences in perceived equipoise
Study
P1094
Prevalence of Chlamydia and Gonorrhea in HIV-infected Pregnant Women in the Americas
Can the Specimen Adequacy Control (SAC) in Cepheid Xpert® CT/NG predict infection?
Safety and Immunogenicity of the Recombinant Live-Attenuated Respiratory syncytial Virus Vaccine RSV cps2 in RSV-seronegative Infants and Children
Conference
IDWeek 2015
Study
P1114